The ASAM Criteria are the clinical standard that dictates placement in US addiction care. Here is a plain-language guide to the six dimensions, the 3rd Edition levels of care, and how to use them to advocate for an appropriate clinical fit.
Last reviewed: April 23, 2026 | Reading time: 11 min | Topic: Placement & advocacy
In this guide
- Why this matters
- What the ASAM Criteria do
- The six dimensions (3rd Edition)
- The 3rd Edition levels of care
- What the Criteria discourage
- The "Capable" tier as the clinical floor
- How to use the Criteria to advocate
Why this matters
If your family is trying to find treatment for someone you love, you have likely been handed a set of assumptions dressed up as clinical facts. "They need 28 days." "Residential is the gold standard." "They have to hit rock bottom." None of these are evidence-based defaults. They are program-specific practices that are out of step with published clinical standards.
That standard is the ASAM Criteria, the American Society of Addiction Medicine Criteria, specifically the widely adopted 3rd Edition (2013).1 The Criteria are the primary set of guidelines in the United States for matching patients with substance use disorders (SUDs) to the appropriate level of care. They are utilized by licensed clinicians, managed-care reviewers, and state Medicaid programs. Understanding their mechanics is one of the most effective ways a family can advocate for care.
What the ASAM Criteria do
The Criteria answer one central question: Given the biopsychosocial presentation of this patient right now, what is the least intensive, safe, and effective level of care?
They do not prescribe a rigid "program" or a predetermined "length of stay." They deliver a level-of-care recommendation. That recommendation is then reassessed regularly as the patient's dimensional profile stabilizes or shifts. A patient might step down from Level 3.5 (High-Intensity Residential) to Level 2.5 (Partial Hospitalization), and eventually to Level 1 (Outpatient) based on clinical progress across active treatment days.
The six dimensions (3rd Edition)
The 3rd Edition relies on a multidimensional assessment. A clinician evaluates the patient across six specific areas to determine the severity and the corresponding level of care.
Dimension 1, Acute Intoxication and/or Withdrawal Potential
What is the immediate medical risk if this person stops using right now? For alcohol and benzodiazepine use disorders, withdrawal can be life-threatening and may require medical supervision. For other substances, withdrawal is uncomfortable but not medically dangerous. This dimension drives the initial decision regarding the necessity of ambulatory (outpatient) versus inpatient withdrawal management.
Dimension 2, Biomedical Conditions and Complications
What other physical health issues are in play? Uncontrolled diabetes, pregnancy, recent cardiac events, or chronic pain on opioid therapy can necessitate a setting with integrated nursing or medical oversight.
Dimension 3, Emotional, Behavioral, or Cognitive Conditions and Complications
What co-occurring mental health issues are present? This dimension assesses active psychiatric symptoms, cognitive functioning, and trauma. Active suicidality, severe untreated bipolar disorder, active psychosis, or significant cognitive impairment shift the placement toward dual-diagnosis enhanced or medically monitored levels.
Dimension 4, Readiness to Change
What is the individual's level of motivation, insight, and willingness to engage in treatment? Someone who is ready to engage can often be treated effectively at a lower level of care. Low readiness does not automatically default to a residential placement; rather, it indicates that the clinical care plan must heavily integrate motivational interviewing and engagement strategies.
Dimension 5, Relapse, Continued Use, or Continued Problem Potential
What is the short-term risk of continued use or a return to use if the current plan is not intensified? If a patient is unable to achieve or maintain abstinence even for the duration of an assessment window, or lacks the coping skills to manage cravings, the required intensity of care increases.
Dimension 6, Recovery/Living Environment
Is the patient's living situation, family, work, school, and social network supportive, neutral, or actively counterproductive to recovery? A highly supportive environment allows for lower levels of care even if other dimensions show moderate severity. Conversely, an unsafe or substance-heavy environment is frequently the primary driver that pushes a recommendation into residential care.
The 3rd Edition levels of care
The 3rd Edition organizes care into a continuum ranging from early intervention to intensive inpatient services.
Level 0.5, Early Intervention
Assessment and education for individuals who are at risk of developing a substance use disorder but do not currently meet diagnostic criteria.
Level 1, Outpatient Services
Less than 9 hours of clinical services per week for adults (less than 6 hours for adolescents). This level is designed for patients who are stable enough to maintain daily functioning while receiving counseling. Note: Opioid Treatment Programs (OTPs) dispensing methadone are categorized as Level 1-OTP.
Level 2.1, Intensive Outpatient Services (IOP)
Nine to nineteen clinical hours per week. Patients continue to sleep at home, engage in their daily lives, and practice coping skills in their actual environment. Research consistently demonstrates outcomes comparable to residential care for appropriately matched patients.2
Level 2.5, Partial Hospitalization Services (PHP)
Twenty or more clinical hours per week. This provides a highly structured day program without overnight boarding. It is often utilized as a direct step-down from an inpatient admission.
Level 3.1, Clinically Managed Low-Intensity Residential Services
A 24-hour supportive environment providing at least 5 hours of clinical services per week. Often referred to as a halfway house, this allows patients to practice reintegration by working or attending school during the day.
Level 3.3, Clinically Managed Population-Specific High-Intensity Residential Services
Adult-only level of care. 24-hour supervision designed specifically for individuals with significant cognitive impairments (e.g., traumatic brain injury or severe mental illness) requiring a slower, more repetitive clinical pace.
Level 3.5, Clinically Managed High-Intensity Residential Services
What is traditionally viewed as "rehab." 24-hour supervision with a high-intensity therapeutic milieu designed for individuals with severe, multidimensional instability.
Level 3.7, Medically Monitored Intensive Inpatient Services
A structured setting providing 24-hour nursing care and physician monitoring for patients experiencing acute withdrawal (Level 3.7-WM) or severe biomedical and psychiatric complications.
Level 4, Medically Managed Intensive Inpatient Services
Hospital-based acute care featuring 24-hour medical and nursing management for the highest clinical acuity.
What the Criteria explicitly discourage
A number of historical industry practices are fundamentally incompatible with multidimensional assessment:
- Menu-driven lengths of stay. Treatment duration must be driven by dimensional progress and measured in active treatment days, not passive calendar milestones like "28 days."
- Requiring abstinence from MOUD to admit. Evidence-based practice within the ASAM framework supports the continuation of FDA-approved addiction medications (buprenorphine, methadone). Refusal to admit patients utilizing MOUD contradicts the clinical standard.
- Punitive discharge for symptom recurrence. A return to use is viewed clinically as an indicator that the current treatment plan or level of care needs adjustment, not as an administrative failure requiring expulsion.
The "Capable" tier as the clinical floor
Because co-occurring mental health conditions (depression, anxiety, PTSD, bipolar disorder) are present in the majority of patients seeking SUD treatment, the ASAM 3rd Edition framework categorizes programs by their ability to handle both:
- Addiction-Only Services (AOS), Addresses SUD exclusively.
- Dual Diagnosis Capable (DDC), Addresses co-occurring mental health issues within the SUD treatment framework.
- Dual Diagnosis Enhanced (DDE), Fully integrated, simultaneous treatment of severe psychiatric and SUD acuity.
While AOS historically existed as a designation, modern clinical consensus firmly establishes "Dual Diagnosis Capable" as the baseline expectation for all addiction treatment. Treating "Capable" care as a specialized commodity is functionally obsolete. If a facility cannot safely and effectively manage common, low-to-moderate acuity psychiatric symptoms concurrently with addiction, they are operating below the expected modern floor.
How to use the Criteria to advocate
If you're the patient or family
- Ask for the driving dimensions. Demand to know exactly which dimensions are justifying the recommended level of care.
- Verify baseline capability. Confirm that the program operates at the Dual Diagnosis Capable tier at minimum.
- Demand treatment-day rationale. Ensure length of stay is anchored to clinical benchmarks and actual treatment days, not predetermined calendar limits.
If you're fighting a payer denial
Federal parity law (MHPAEA) requires commercial payers to utilize generally accepted standards of care, which widely points to the ASAM Criteria. If an insurance company issues a denial:
- Request the utilization review criteria in writing. Compare their cited criteria directly against the ASAM 3rd Edition standards for the disputed level of care.
- Obtain a dimensional letter of medical necessity. Have the treating clinician write a targeted appeal that explicitly links the patient's symptoms to the specific ASAM dimensions.
- Exhaust internal appeals, then file externally. Utilize the external review process managed by your state's department of banking and insurance. Fact-based, dimensionally grounded appeals frequently overturn initial payer denials.
The underlying message
The ASAM Criteria remove the guesswork from addiction care placement. They transform "what kind of treatment?" from a consumer choice into an audit-ready, clinical calculation rooted in six dimensions. When deployed accurately, they protect patients from dangerous under-treatment and prevent the systemic waste of over-treatment.
What to read next
- Ways to Avoid Rehab: The Evidence-Based Guide
- The ASAM 4th Edition Criteria, Explained for Families
- How to Appeal an Insurance Denial for SUD Care (coming soon)
- What "Dual Diagnosis Capable" Actually Means (coming soon)
AvoidRehab Editorial Team
Clinically reviewed by licensed clinicians with expertise in substance use disorder. Last reviewed April 23, 2026.
Sources
Sources
-
Mee-Lee D, Shulman GD, Fishman MJ, Gastfriend DR, Miller MM, eds. The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions. 3rd ed. Carson City, NV: The Change Companies; 2013. ↩
-
McCarty D, Braude L, Lyman DR, et al. Substance Abuse Intensive Outpatient Programs: Assessing the Evidence. Psychiatric Services. 2014;65(6):718-726. ↩
What to read next
Most people with substance use disorders can be treated effectively without residential rehab. Outpatient care, medications, and harm reduction are real options backed by clinical evidence. You do not have to make a permanent decision today. The next step can be small.